Skip to Content

Bath & Body Works, Inc.

Securities Class Action

  • Date:
  • 3/16/2026
  • Company Name:
  • Bath & Body Works, Inc.
  • Stock Symbol:
  • BBWI
  • Class Period:
  • FROM 6/4/2024 TO 11/19/2025
  • Status:
  • Filed
  • Filing Date:
  • 1/12/2026

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE:BBWI) in the United States District Court for the Southern District of Ohio on behalf of all persons and entities who purchased or otherwise acquired Bath & Body Works securities between June 4, 2024 and November 19, 2025, both dates inclusive (the “Class Period”). Investors have until March 16, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 
According to the complaint, defendants failed to disclose to investors: (1) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (2) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; and (3) as a result, the Company was unlikely to meet its own previously issued financial guidance. 

Plaintiff alleges that on November 20, 2025, Bath & Body Works released disappointing third quarter 2025 financial results, including that revenue declined 1% year over year, missed guidance of 1-3% growth for the quarter, and a decline in net income by 26% to $77 million. The Company slashed full-year guidance for net sales and cut expected earnings per diluted share from $3.28 to $3.53 to "at least $2.83." 

In an investor presentation published the same day, the Company announced a new business strategy and admitted its strategy of "adjacencies, collaborations and promotions" had "not grown our total customer base." The Company also offered a "diagnosis" of its underperformance, including that the focus on adjacencies had "reduced focus on investing in our core categories;" that collaborations "have been used to carry quarters;" and that the Company had become "overly reliant on deeper and more frequent promotions to drive growth. " The Company announced would exit certain adjacencies and instead focus on core categories. 

On this news, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025 
 
If you purchased or otherwise acquired Bath & Body Works shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions regarding the case.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Bath & Body Works. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: